communityacquir
pneumonia
cap
infect
distal
part
breath
airway
pulmonari
parenchyma
extrahospit
environ
spite
develop
new
antibiot
vaccin
communityacquir
pneumonia
still
frequent
occur
diseas
usual
present
children
year
age
one
main
caus
mortal
annual
worldwid
especi
develop
countri
million
death
correspond
children
chile
main
caus
pediatr
hospitalm
l
boza
costagliola
pediatr
respiratori
diseas
univers
chile
santiago
chile
izat
winter
spring
correspond
hospit
admiss
hospit
first
year
life
first
caus
late
infant
mortal
ratio
children
year
old
although
experi
dramat
decreas
sinc
mortal
rate
communityacquir
pneumonia
see
minsal
current
infect
caus
human
immunodefici
viru
hiv
increas
number
death
caus
pneumonia
risk
six
time
higher
comparison
infect
particularli
underdevelop
countri
biggest
challeng
pneumonia
determin
caus
agent
identif
depend
factor
age
diseas
sever
immunolog
condit
geograph
locat
year
season
epidemiolog
situat
immun
therefor
identif
caus
agent
vari
depend
method
use
etiolog
differ
accord
patient
age
newborn
group
b
streptococcu
gramneg
bacteria
common
agent
infant
common
agent
usual
viru
correspond
chile
exampl
wherea
develop
countri
percentag
increas
among
viral
agent
respiratori
syncyti
viru
rsv
frequent
agent
adenoviru
caus
seriou
diseas
serotyp
among
common
etiolog
agent
mention
influenza
parainfluenza
metapneumoviru
human
metapneumoviru
hmpv
caus
lower
respiratori
infect
age
group
past
year
rhinoviru
coronaviru
also
describ
caus
communityacquir
pneumonia
bacteri
etiolog
increas
age
mani
hospit
children
older
year
streptococcu
pneumonia
caus
common
bacteri
infect
age
predomin
winter
spring
time
bacteria
includ
haemophilu
influenza
rare
caus
agent
mandatori
vaccin
although
nontypifi
serotyp
caus
seriou
present
staphylococcu
aureu
quick
seriou
progress
current
except
streptococcu
pyogen
variabl
clinic
cours
may
caus
seriou
diseas
shock
pulmonari
suppur
less
frequent
agent
includ
chlamydia
trachomati
infect
acquir
birth
canal
clinic
onset
week
life
includ
fever
involv
tachypnea
rhiniti
conjunct
cough
fit
hemogram
show
eosinophilia
chest
xray
unspecif
show
interstiti
pattern
predomin
bordetella
pertussi
caus
whoop
cough
clinic
syndrom
mainli
interstiti
pulmonari
compromis
atyp
agent
mycoplasma
pneumonia
chlamydia
pneumonia
common
caus
agent
children
age
year
respect
tabl
coinfect
differ
pathogen
possibl
frequent
combin
rsv
influenza
viru
streptococcu
pneumonia
case
mycoplasma
pneumonia
streptococcu
pneumonia
chlamydia
pneumonia
case
tabl
follow
factor
protect
respiratori
system
infect
mechan
nasal
filter
inhal
air
gag
reflex
cough
reflex
mucociliari
clearanc
immunolog
involv
alveolar
macrophag
immunoglobulin
local
inflammatori
respons
complement
cytokin
antiproteas
lysozym
fibronectin
immun
cellular
respons
normal
circumst
mucociliari
clearanc
remov
effici
inhal
agent
howev
inoculum
big
agent
especi
aggress
defens
mechan
alter
pulmonari
parenchyma
develop
infect
inhal
infecti
agent
viru
bacteria
aspir
germ
mouth
upper
airway
bacteria
common
contigu
hematogen
spread
endogen
reactiv
tuberculosi
rare
bacteria
caus
alveolar
damag
accompani
inflammatori
exud
edema
fibrin
afterward
invas
polymorphonuclear
leukocyt
gener
resolut
complet
almost
alway
function
compromis
viru
caus
epitheli
damag
may
progress
necrosi
diffus
alveolar
damag
vari
degre
evid
suggest
viru
could
factor
increas
bacteri
infect
may
take
advantag
alter
mechan
immunolog
barrier
host
clinic
pictur
fluctuat
serious
depend
age
etiolog
agent
extens
classic
triad
fever
cough
respiratori
distress
nevertheless
cough
may
appear
later
receptor
lower
airway
irrit
cellular
lysi
inflammatori
exud
appear
newborn
histori
prematur
membran
ruptur
relat
respiratori
distress
first
hour
life
along
cardiovascular
collaps
group
b
streptococcu
must
suspect
infant
month
old
frequent
present
tachypnea
usual
breath
per
minut
along
retract
soft
chest
structur
frequent
associ
unspecif
symptom
hypothermia
hyperthermia
fatigu
food
intoler
somnol
diarrhea
apnea
high
fever
must
alert
clinician
rule
septic
shock
secondari
respiratori
infect
older
infant
usual
histori
upper
airway
symptom
cough
rhinorrhea
soon
fever
tachypnea
gener
statu
deterior
grunt
nasal
flare
appear
high
fever
especi
year
old
relat
serious
diseas
although
sign
use
determin
specif
etiolog
preschool
schoolag
children
present
high
fever
accompani
shiver
cough
chest
pain
pain
resembl
side
stitch
abdomin
pain
may
present
compromis
inferior
lobul
often
acut
append
must
rule
particularli
schoolag
children
pain
shoulder
area
suggest
pleural
compromis
dri
product
cough
rhinorrhea
gener
discomfort
headach
myalgia
abdomin
pain
nonspecif
sign
may
may
accompani
bacteri
viral
infect
physic
examin
result
vari
fluctuat
depend
age
patient
tachypnea
sensit
sign
patient
year
old
younger
infant
newborn
present
reduc
breath
sound
crackl
condens
syndromebronchophoni
dull
percuss
bronchial
murmur
fine
cracklesi
frequent
present
children
year
age
crackl
sensit
specif
less
wheez
may
present
infant
viral
pneumonia
children
year
old
atyp
pneumonia
agent
mycoplasma
pneumonia
normal
respiratori
examin
rule
pneumonia
especi
first
h
name
silent
period
diagnosi
suspicion
mainli
clinic
routin
chest
xray
need
diagnosi
ambulatori
set
administr
treatment
must
delay
howev
chest
xray
consid
gold
standard
confirm
diagnosi
communityacquir
pneumonia
except
acquir
earli
h
clinic
progress
sensibl
low
chest
xray
differenti
among
bacteri
viral
atyp
agent
lobar
condens
pattern
suggest
bacteri
infect
interstiti
pattern
suggest
viral
atyp
agent
infect
fig
chest
xray
best
use
rule
pneumoni
complic
empyema
abscess
clinic
pictur
show
persist
fever
start
antibiot
treatment
andor
dull
percuss
chest
present
acut
respiratori
difficulti
syndrom
accompani
hypoxemia
andor
hemodynam
instabl
chest
xray
mandatori
test
also
must
consid
patient
respons
treatment
lobar
atelectasi
roundshap
consolid
persist
symptom
complic
pneumonia
chest
xray
followup
week
must
done
case
recurr
pneumonia
lobar
atelectasi
suspicion
malform
slowresolut
pneumonia
fig
chest
echographi
use
suspicion
effus
evalu
amount
presenc
septa
recollect
area
white
cell
blood
count
neutrophil
count
creactiv
protein
sediment
rate
procalcitonin
use
identifi
etiolog
sever
prospect
studi
proven
acutephas
reactant
low
sensit
microbiolog
identif
clinic
impact
children
communityacquir
pneumonia
nevertheless
patient
undergo
seriou
cours
andor
hospit
etiolog
investig
import
face
possibl
viral
etiolog
direct
immunofluoresc
dif
elisa
test
use
although
must
consid
adenoviru
sensit
greater
case
dif
incub
cell
shellvial
techniqu
yield
better
result
advis
request
techniqu
case
neg
result
high
clinic
suspicion
current
amplif
specif
viral
genom
fragment
high
sensit
specif
use
minimum
quantiti
dna
simultan
detect
multipl
viru
easi
standard
quick
result
h
therefor
use
hospit
patient
face
possibl
bacteri
infect
hemat
cultur
low
posit
rate
consid
patient
show
poor
clinic
respons
infant
hemat
cultur
yield
poorli
around
similar
older
children
patient
pleural
effus
direct
pleural
space
gram
stain
cultur
less
posit
nevertheless
cytochem
analysi
help
precis
locat
empyema
older
children
gram
stain
expector
cultur
may
use
agent
differ
usual
colon
upper
airway
particularli
intracellular
locat
correspond
macrophag
polymorphonuclear
leukocyt
valid
sampl
necessari
least
white
blood
cell
fewer
epitheli
cell
per
field
serum
antigen
detect
streptococcu
pneumonia
haemophilu
influenza
blood
urin
pleural
effus
liquid
low
specif
sensit
yield
falseposit
nasopharyng
colon
patient
recent
receiv
immun
therefor
recommend
combin
urin
antigen
acutephas
reactant
may
good
predictor
bacteri
pneumonia
effect
immun
complex
streptococcu
pneumonia
shown
better
specif
sensit
diagnos
mycoplasma
pneumonia
chlamydia
pneumonia
serum
test
igm
use
limit
allow
diagnosi
first
week
therefor
use
earli
diagnosi
protein
chain
reaction
pcr
techniqu
sensit
specif
diagnosi
done
earli
rapidli
within
progress
diseas
invas
method
bronchoalveolar
lavag
bal
may
better
result
indic
communityacquir
pneumonia
restrict
patient
complic
cours
gener
poor
respons
empir
treatment
serolog
fast
microbiolog
method
pcr
elisa
dif
fail
yield
diagnosi
observ
especi
true
immunocompromis
patient
present
feverish
neutropenia
lymphopenia
aid
bone
marrow
anoth
organ
transplant
treat
patient
especi
pneumocysti
jirovecii
suspect
suggest
obtain
induc
sputum
sampl
noninvas
method
may
effect
secur
relationship
bronchoalveolar
lavag
difficult
make
etiolog
differenti
diagnosi
pneumonia
recurr
event
diseas
may
explain
origin
tabl
patient
respond
outpati
treatment
infant
medic
monitor
recommend
h
preschool
h
monitor
must
foreseen
worsen
condit
caus
food
reject
medic
intoler
increas
respiratori
difficulti
irrit
persist
cri
compromis
conscious
use
antipyret
analges
indic
keep
child
better
condit
reduc
metabol
oxygen
requir
physician
must
insist
caregiv
look
medic
advic
case
symptom
worsen
axillar
fever
greater
longer
day
respiratori
difficulti
tachypnea
cyanosi
rib
retract
food
reject
notabl
weak
kinesiotherapi
indic
pneumonia
manag
acceler
recoveri
process
may
delay
symptom
progress
cough
assist
techniqu
postur
drainag
diaphragmat
reeduc
earli
mobil
may
help
expand
poorli
ventil
area
improv
symptom
respiratori
distress
achiev
object
antibiot
treatment
empir
given
difficulti
isol
etiolog
agent
base
best
possibl
etiolog
depend
patient
age
epidemiolog
time
children
year
old
antibiot
routin
indic
case
diseas
caus
viru
bacteri
etiolog
suspect
amoxicillin
prescrib
mgkgday
fraction
everi
h
day
use
maximum
gday
children
year
old
amoxicillin
prescrib
mgkgday
poor
oral
toler
sodium
penicillin
use
follow
ukgday
iv
everi
h
maximum
million
uday
toler
recov
continu
oral
amoxicillin
use
macrolid
consid
older
children
suspect
mycoplasma
pneumonia
chlamydia
pneumonia
penicillin
allergi
azitromicin
mgkgday
daili
dosag
without
food
day
maximum
mgday
claritromicin
mgkgday
everi
h
day
maximum
gday
erythromycin
mgkgday
divid
four
dose
day
maximum
gday
altern
macrolid
use
quinolon
indic
daili
levofloxacin
mgkg
dose
day
epidem
episod
influenza
viru
must
rule
earli
treatment
antivir
oseltamivir
must
start
clinic
respons
outpati
therapi
vomit
dehydr
may
make
oral
treatment
difficult
total
partial
respiratori
insuffici
transcutan
satur
month
age
apnea
risk
cardiorespiratori
arrest
relev
comorbid
cardiac
pulmonari
neuromuscular
immunolog
complic
pneumonia
effus
excav
lesion
seriou
diseas
hemodynam
instabl
alter
conscious
seizur
toxic
present
oxygen
patient
whose
satur
less
mmhg
environ
air
avoid
prolong
fast
especi
infant
year
old
recommend
administ
fraction
feed
feed
small
volum
small
nasogastr
tube
avoid
worsen
respiratori
difficulti
newborn
infant
week
old
ampicillin
mgkgday
everi
h
iv
plu
amikacin
mgkg
h
iv
day
ensur
good
coverag
enter
gramneg
bacteria
group
b
streptococcu
type
enterococcu
listeria
monocytogen
first
week
life
altern
amikacin
cefotaxim
indic
mgkgday
given
lower
risk
listeria
monocytogen
may
requir
ad
ampicillin
synerg
effect
aminoglycosid
patient
progress
worsen
resist
streptococcu
pneumonia
suspect
high
dose
amoxicillin
thirdor
secondgener
cephalosporin
iv
ampicillin
use
ampicillin
deriv
penicillin
good
choic
patient
month
age
similar
effici
oral
amoxicillin
parenter
cephalosporin
significantli
lesser
cost
associ
macrolid
beta
lactam
antibiot
indic
hospit
children
strong
suspicion
atyp
agent
infect
caus
staphylococcu
aureu
depend
sensit
cloxacillin
clindamycin
vancomycin
indic
appear
resist
streptococcu
worldwid
concern
degre
resist
degre
variabl
depend
geograph
distribut
risk
invas
diseas
caus
resist
streptococcu
pneumonia
relat
year
old
younger
special
year
old
use
antibiot
within
preced
month
middleear
infect
daycar
attend
resist
caus
mutat
penicillin
proteinbind
ppb
site
reduct
protein
affin
bind
antibiot
genet
chang
caus
dna
acquisit
resist
speci
streptococcu
viridan
reduct
affin
could
counter
increas
penicillin
dosag
use
thirdgener
cephalosporin
observ
made
patient
communityacquir
pneumonia
caus
resist
streptococcu
pneumonia
still
good
respons
treatment
increas
chosen
cutoff
point
determin
penicillin
cefotaxim
resist
cim
ugml
whenev
patient
persist
fever
h
presenc
complic
effus
pleural
empyema
abscess
pneumatocel
bacteri
resist
choic
inadequ
antibiot
must
suspect
presenc
extrapulmonari
focu
pericardium
joint
mening
must
rule
pleural
effus
empyema
possibl
complic
hospit
children
use
vaccin
bordetella
pertussi
measl
haemophilu
influenza
influenza
reduc
occurr
communityacquir
pneumonia
import
effect
regist
relat
prevent
suppur
complic
incorpor
vaccin
type
b
haemophilu
influenza
nation
rate
invas
diseas
report
inhabit
effect
prevent
bacteri
communityacquir
pneumonia
empyema
must
consid
infect
caus
haemophilu
influenza
caus
noncapsul
agent
vaccin
offer
protect
influenza
vaccin
doubl
effect
reduc
viru
infect
rate
highrisk
popul
parallel
effect
decreas
bacteri
communityacquir
pneumonia
caus
streptococcu
pneumonia
staphylococcu
aureu
relat
postinfluenza
viru
infect
chile
mandatori
vaccin
introduc
risk
group
pneumonia
incid
clearli
reduc
children
year
old
pneumococc
conjug
vaccin
less
effect
prevent
pneumonia
invas
diseas
sepsi
mening
vaccin
good
immunogen
herd
immun
vaccin
includ
v
serotyp
prematur
newborn
chronic
lung
damag
risk
factor
must
receiv
monoclon
antibodi
prophylaxi
syncyti
respiratori
viru
communityacquir
pneumonia
still
preval
diseas
children
etiolog
diagnosi
done
xray
studi
hemogram
acutephas
reactant
develop
materi
rapid
diagnosi
unmet
need
requir
avoid
indiscrimin
use
antibiot
import
factor
appear
bacteri
resist
penicillin
deriv
especi
oral
amoxicillin
continu
treatment
choic
streptococcu
pneumonia
suspect
macrolid
use
pneumonia
caus
atyp
agent
suspect
especi
schoolchildren
year
old
coverag
effect
vaccin
import
accord
region
need
may
contribut
prevent
diseas
nation
program
systemat
appli
primari
care
coverag
contribut
signific
decreas
morbid
mortal
